相关实验视频
Updated: Sep 16, 2025

11:11
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
16.9K
对CDKN2A外2的DNA甲基化和转录变异分析,尽管与CDKN2B外2具有高序列相同性
Katja Zappe1, Andreas Jenik1, Daniel Berger1
1Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.
International journal of molecular sciences
|July 12, 2025
概括
一种新的热测序试验准确地测量了CDKN2A外因子2中的DNA甲基化,这对于了解瘤抑制剂p16INK4a在癌症中的调节至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 由CDKN2A编码的瘤抑制剂p16INK4a在癌症中经常被禁用.
- 促剂高甲基化是一种常见的表观遗传原因,但异常的CDKN2A外2甲基化也会发生.
- 由于与CDKN2B的序列相似性,分析CDKN2A外2甲基化是很困难的.
研究的目的:
- 开发一种新的热测序试验,用于准确分析CDKN2A外2DNA甲基化.
- 调查促进体和外子2甲基化在调节CDKN2A表达中的作用.
- 为了将测试应用于质瘤和乳腺癌细胞系.
主要方法:
- 开发了一种用于同源CDKN2A和CDKN2B区域的联合放大新型原料组的火烧测序试验.
- 量化CDKN2A比例用于确定CDKN2A外2中CpG的甲基化水平.
- 检查了促进体甲基化,mRNA和蛋白质表达,以及其他 (epi) 遗传变化.
主要成果:
- 该试验准确地确定了CDKN2A外2中的CpG的甲基化水平.
- 观察到一系列的 (epi) 基因变化,包括同卵性缺失,转录特异性表达和外因子2跳转.
- 发现促进物和异子2甲基化都对CDKN2A的表达调节有所贡献.
结论:
- 一种新的热测序方法使CDKN2A外2甲基化的准确分析成为可能.
- 在促进子和异子2中的异常甲基化在癌症中对CDKN2A调节起作用.
- 这种方法是未来对CDKN2A.癌症研究的一个有价值的工具.
相关概念视频
Comparing Copy Number Variations and SNPs
17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Epigenetic Regulation
31.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.4K
Histone Variants at the Centromere
4.5K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.5K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K

